Follow
Andres Deik
Title
Cited by
Cited by
Year
A new in vitro model of the glial scar inhibits axon growth
IB Wanner, A Deik, M Torres, A Rosendahl, JT Neary, VP Lemmon, ...
Glia 56 (15), 1691-1709, 2008
1892008
The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease
Z Gan-Or, LJ Ozelius, A Bar-Shira, R Saunders-Pullman, A Mirelman, ...
Neurology 80 (17), 1606-1610, 2013
1802013
Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium
K Marder, Y Wang, RN Alcalay, H Mejia-Santana, MX Tang, A Lee, ...
Neurology 85 (1), 89-95, 2015
1602015
Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutations
RN Alcalay, A Mirelman, R Saunders‐Pullman, MX Tang, ...
Movement Disorders 28 (14), 1966-1971, 2013
1372013
Clinical spectrum of stiff person syndrome: a review of recent reports
H Sarva, A Deik, A Ullah, WL Severt
Tremor and Other Hyperkinetic Movements 6, 2016
1032016
Effect of urate-elevating inosine on early Parkinson disease progression: the SURE-PD3 randomized clinical trial
B Bluett, DM Togasaki, D Mihaila, M Evatt, M Rezak, S Jain, ...
Jama 326 (10), 926-939, 2021
822021
Reorganization of corticostriatal circuits in healthy G2019S LRRK2 carriers
RC Helmich, A Thaler, BFL Van Nuenen, T Gurevich, A Mirelman, ...
Neurology 84 (4), 399-406, 2015
802015
Fall risk and gait in Parkinson's disease: the role of the LRRK2 G2019S mutation
A Mirelman, T Heman, K Yasinovsky, A Thaler, T Gurevich, K Marder, ...
Movement Disorders 28 (12), 1683-1690, 2013
802013
Substance abuse and movement disorders: complex interactions and comorbidities
A Deik, R Saunders-Pullman, M San Luciano
Current drug abuse reviews 5 (3), 243-253, 2012
792012
Lower cognitive performance in healthy G2019S LRRK2 mutation carriers
A Thaler, A Mirelman, T Gurevich, E Simon, A Orr-Urtreger, K Marder, ...
Neurology 79 (10), 1027-1032, 2012
742012
Nonsteroidal Anti‐inflammatory Use and LRRK2 Parkinson's Disease Penetrance
M San Luciano, CM Tanner, C Meng, C Marras, SM Goldman, AE Lang, ...
Movement Disorders 35 (10), 1755-1764, 2020
682020
Pathophysiology and treatment of alien hand syndrome
H Sarva, A Deik, WL Severt
Tremor and Other Hyperkinetic Movements 4, 2014
622014
Neuropsychiatric characteristics of GBA-associated Parkinson disease
M Swan, N Doan, RA Ortega, M Barrett, W Nichols, L Ozelius, ...
Journal of the neurological sciences 370, 63-69, 2016
572016
A phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson's disease (PASADENA): rationale, design, and baseline data
G Pagano, FG Boess, KI Taylor, B Ricci, B Mollenhauer, W Poewe, ...
Frontiers in neurology 12, 705407, 2021
512021
Heterogeneity in primary dystonia: Lessons from THAP1, GNAL, and TOR1A in Amish‐Mennonites
R Saunders‐Pullman, T Fuchs, M San Luciano, D Raymond, A Brashear, ...
Movement Disorders 29 (6), 812-818, 2014
442014
Atypical presentation of late‐onset Tay‐sachs disease
A Deik, R Saunders‐Pullman
Muscle & nerve 49 (5), 768-771, 2014
362014
Compound heterozygous PNPLA6 mutations cause Boucher–Neuhäuser syndrome with late-onset ataxia
A Deik, B Johannes, JC Rucker, E Sánchez, SE Brodie, E Deegan, ...
Journal of neurology 261, 2411-2423, 2014
352014
Impact of dyskinesia on activities of daily living in Parkinson's disease: results from pooled phase 3 ADS-5102 clinical trials
R Pahwa, S Isaacson, J Jimenez-Shaheed, IA Malaty, A Deik, R Johnson, ...
Parkinsonism & related disorders 60, 118-125, 2019
322019
Cognitive profile and markers of Alzheimer disease–type pathology in patients with Lewy body dementias
E Howard, DJ Irwin, K Rascovsky, N Nevler, S Shellikeri, TF Tropea, ...
Neurology 96 (14), e1855-e1864, 2021
302021
Transcranial sonography and functional imaging in glucocerebrosidase mutation Parkinson disease
MJ Barrett, J Hagenah, V Dhawan, S Peng, K Stanley, D Raymond, ...
Parkinsonism & related disorders 19 (2), 186-191, 2013
292013
The system can't perform the operation now. Try again later.
Articles 1–20